Daiwa Securities Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Hold |
272
| – | – | ﹤0.01% | 1105 |
|
|
2025
Q1 | $11K | Buy |
272
+10
| +4% | +$404 | ﹤0.01% | 1089 |
|
|
2024
Q4 | $7K | Hold |
262
| – | – | ﹤0.01% | 1140 |
|
|
2024
Q3 | $8K | Hold |
262
| – | – | ﹤0.01% | 1140 |
|
|
2024
Q2 | $6K | Buy |
262
+74
| +39% | +$1.7K | ﹤0.01% | 1176 |
|
|
2024
Q1 | $5K | Hold |
188
| – | – | ﹤0.01% | 1195 |
|
|
2023
Q4 | $4K | Hold |
188
| – | – | ﹤0.01% | 1206 |
|
|
2023
Q3 | $10K | Hold |
188
| – | – | ﹤0.01% | 1119 |
|
|
2023
Q2 | $9K | Hold |
188
| – | – | ﹤0.01% | 1133 |
|
|
2023
Q1 | $7K | Hold |
188
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q4 | $10K | Buy |
188
+69
| +58% | +$3.67K | ﹤0.01% | 1108 |
|
|
2022
Q3 | $4K | Hold |
119
| – | – | ﹤0.01% | 1163 |
|
|
2022
Q2 | $1K | Hold |
119
| – | – | ﹤0.01% | 1261 |
|
|
2022
Q1 | $2K | Hold |
119
| – | – | ﹤0.01% | 1231 |
|
|
2021
Q4 | $3K | Hold |
119
| – | – | ﹤0.01% | 1226 |
|
|
2021
Q3 | $3K | Buy |
119
+54
| +83% | +$1.36K | ﹤0.01% | 1202 |
|
|
2021
Q2 | $2K | Hold |
65
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q1 | $2K | Hold |
65
| – | – | ﹤0.01% | 1131 |
|
|
2020
Q4 | $2K | Sell |
65
-96
| -60% | -$2.95K | ﹤0.01% | 1104 |
|
|
2020
Q3 | $5K | Hold |
161
| – | – | ﹤0.01% | 1074 |
|
|
2020
Q2 | $3K | Hold |
161
| – | – | ﹤0.01% | 1116 |
|
|
2020
Q1 | $3K | Hold |
161
| – | – | ﹤0.01% | 1118 |
|
|
2019
Q4 | $4K | Buy |
+161
| New | +$4K | ﹤0.01% | 1107 |
|